ロード中...
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
Abstract Background We previously reported that low-dose, short-course sunitinib prior to neoadjuvant doxorubicin-cyclophosphamide (AC) normalised tumour vasculature and improved perfusion, but resulted in neutropenia and delayed subsequent cycles in breast cancer patients. This study combined sunit...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2020-11-01
|
| シリーズ: | BMC Cancer |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s12885-020-07616-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|